Surgical Science Sweden AB (publ) (SUSRF)

Market Cap	763.54M
Revenue (ttm)	94.30M
Net Income (ttm)	14.06M
Shares Out	n/a
EPS (ttm)	0.27
PE Ratio	54.32
Forward PE	31.88
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,200
Average Volume	2,044
Open	14.60
Previous Close	n/a
Day's Range	14.60 - 14.81
52-Week Range	11.30 - 15.25
Beta	0.62
RSI	58.10
Earnings Date	May 14, 2025

About SUSRF

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy tra...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1997
• Employees: 274
• Stock Exchange: OTCMKTS
• Ticker Symbol: SUSRF

Financial Performance

In 2024, SUSRF's revenue was 884.09 million, an increase of 0.14% compared to the previous year's 882.85 million. Earnings were 131.65 million, a decrease of -43.73%.

Financial numbers in SEK